Russell Investments Group Ltd. Sells 7,929 Shares of Astera Labs, Inc. $ALAB

Russell Investments Group Ltd. decreased its holdings in shares of Astera Labs, Inc. (NASDAQ:ALAB - Free Report) by 69.3% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,507 shares of the company's stock after selling 7,929 shares during the period. Russell Investments Group Ltd.'s holdings in Astera Labs were worth $209,000 at the end of the most recent reporting period.

• 4 Stocks Every AI ETF Is Buying—And They’re Not What You Think

Several other institutional investors and hedge funds also recently made changes to their positions in ALAB. Sound Income Strategies LLC raised its stake in Astera Labs by 34.7% during the 1st quarter. Sound Income Strategies LLC now owns 792 shares of the company's stock worth $47,000 after buying an additional 204 shares during the period. GAMMA Investing LLC increased its position in shares of Astera Labs by 55.7% during the first quarter. GAMMA Investing LLC now owns 794 shares of the company's stock valued at $47,000 after acquiring an additional 284 shares during the last quarter. Harbour Investments Inc. grew its holdings in Astera Labs by 351.7% during the first quarter. Harbour Investments Inc. now owns 795 shares of the company's stock valued at $47,000 after purchasing an additional 619 shares during the period. Migdal Insurance & Financial Holdings Ltd. bought a new position in Astera Labs during the first quarter valued at $48,000. Finally, Hazlett Burt & Watson Inc. grew its holdings in Astera Labs by 1,670.0% during the first quarter. Hazlett Burt & Watson Inc. now owns 885 shares of the company's stock valued at $53,000 after purchasing an additional 835 shares during the period. Institutional investors own 60.47% of the company's stock.

Insiders Place Their Bets

In other Astera Labs news, COO Sanjay Gajendra sold 280,000 shares of the company's stock in a transaction that occurred on Thursday, August 7th. The stock was sold at an average price of $170.02, for a total transaction of $47,605,600.00. Following the transaction, the chief operating officer owned 5,525,545 shares in the company, valued at approximately $939,453,160.90. This represents a 4.82% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Michael Truett Tate sold 100,000 shares of the company's stock in a transaction that occurred on Thursday, August 7th. The stock was sold at an average price of $171.38, for a total value of $17,138,000.00. Following the transaction, the chief financial officer owned 518,996 shares in the company, valued at $88,945,534.48. This trade represents a 16.16% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 1,649,489 shares of company stock worth $232,463,986. Company insiders own 12.50% of the company's stock.

Astera Labs Price Performance

• MarketBeat Week in Review – 06/23 - 6/27

Shares of NASDAQ:ALAB opened at $174.24 on Wednesday. Astera Labs, Inc. has a 1 year low of $36.85 and a 1 year high of $199.47. The stock's 50-day moving average is $136.10 and its 200 day moving average is $96.96. The company has a market cap of $28.96 billion, a PE ratio of 311.14, a P/E/G ratio of 4.62 and a beta of 1.48.

Astera Labs (NASDAQ:ALAB - Get Free Report) last posted its earnings results on Tuesday, August 5th. The company reported $0.44 earnings per share for the quarter, topping analysts' consensus estimates of $0.33 by $0.11. Astera Labs had a return on equity of 9.53% and a net margin of 16.54%.The firm had revenue of $191.93 million for the quarter, compared to the consensus estimate of $172.46 million. During the same quarter in the prior year, the business earned $0.13 EPS. The business's revenue for the quarter was up 149.5% on a year-over-year basis. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. Analysts expect that Astera Labs, Inc. will post 0.34 EPS for the current fiscal year.

Analysts Set New Price Targets

• Astera Labs: AI Infrastructure Play With Significant Growth Ahead

A number of equities analysts have recently commented on the company. Northland Capmk lowered Astera Labs from a "strong-buy" rating to a "hold" rating in a report on Tuesday, July 22nd. Barclays restated an "overweight" rating and set a $155.00 price target (up previously from $75.00) on shares of Astera Labs in a research report on Thursday, August 7th. CICC Research began coverage on Astera Labs in a research report on Friday, August 29th. They set an "outperform" rating and a $190.00 price target on the stock. Deutsche Bank Aktiengesellschaft lifted their price objective on Astera Labs from $160.00 to $200.00 and gave the stock a "buy" rating in a report on Tuesday. Finally, Northland Securities downgraded Astera Labs from an "outperform" rating to a "market perform" rating and set a $120.00 price target on the stock. in a report on Tuesday, July 22nd. One research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat.com, Astera Labs presently has a consensus rating of "Moderate Buy" and an average price target of $142.00.

Get Our Latest Stock Analysis on Astera Labs

About Astera Labs

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

Recommended Stories

• Five stocks we like better than Astera Labs
• How to Invest in Small Cap Stocks
• Amazon Faces Rare Downgrade—Is the Rally at Risk?
• Dividend Payout Ratio Calculator
• CrowdStrike Tests $412 Support as Options Traders Turn Bullish
• Comparing and Trading High PE Ratio Stocks
• Dueling Insider Moves: Heavy Buying Here, Big Selling There

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Astera Labs Right Now?

Before you consider Astera Labs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astera Labs wasn't on the list.

While Astera Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here